{"entity":{"type":"insider","cik":"0001457130","url":"/insider/0001457130","json_url":"/insider/0001457130.json","name":"Spink Katharine E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":13,"first":"2009-05-28","last":"2017-01-11","span_basis":"filed_date"},"name_variants":[{"name":"Spink Katharine E.","source":"filing","n_filings":13,"first_seen":"2009-05-28","last_seen":"2017-01-11"}],"transactions":[{"id":4993379,"accession":"0001140361-17-001563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-001563","line_url":"/filing/0001140361-17-001563#line-2","is_derivative":false,"issuer_cik":"0001457130","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"AST","issuer_name_source":null,"issuer_url":"/issuer/0001457130","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4781.0,"shares_display":"4,781","price_per_share":4.603,"price_display":"4.60","price_state":"stated","total_value":22006.943,"total_display":"22,006.94","total_whole":"22,007","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-09","filed_date":"2017-01-11","scope":"insider"},{"id":4782292,"accession":"0001140361-17-001018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-001018","line_url":"/filing/0001140361-17-001018#line-2","is_derivative":false,"issuer_cik":"0001457130","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"AST","issuer_name_source":null,"issuer_url":"/issuer/0001457130","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-27","filed_date":"2017-01-06","scope":"insider"},{"id":3123099,"accession":"0001140361-16-087951","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-087951","line_url":"/filing/0001140361-16-087951#line-2","is_derivative":false,"issuer_cik":"0001457130","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"AST","issuer_name_source":null,"issuer_url":"/issuer/0001457130","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":5.41,"price_display":"5.41","price_state":"stated","total_value":13525.0,"total_display":"13,525.00","total_whole":"13,525","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-23","filed_date":"2016-11-28","scope":"insider"},{"id":2088532,"accession":"0001140361-16-087413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-087413","line_url":"/filing/0001140361-16-087413#line-2","is_derivative":false,"issuer_cik":"0001457130","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"AST","issuer_name_source":null,"issuer_url":"/issuer/0001457130","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-17","filed_date":"2016-11-21","scope":"insider"},{"id":2217260,"accession":"0001140361-16-082361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-082361","line_url":"/filing/0001140361-16-082361#line-2","is_derivative":false,"issuer_cik":"0001457130","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"AST","issuer_name_source":null,"issuer_url":"/issuer/0001457130","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4781.0,"shares_display":"4,781","price_per_share":4.1068,"price_display":"4.11","price_state":"stated","total_value":19634.6108,"total_display":"19,634.61","total_whole":"19,635","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-06","filed_date":"2016-10-11","scope":"insider"},{"id":2911601,"accession":"0001140361-16-079565","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-079565","line_url":"/filing/0001140361-16-079565#line-2","is_derivative":false,"issuer_cik":"0001457130","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"AST","issuer_name_source":null,"issuer_url":"/issuer/0001457130","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9608.0,"shares_display":"9,608","price_per_share":3.5376,"price_display":"3.54","price_state":"stated","total_value":33989.2608,"total_display":"33,989.26","total_whole":"33,989","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-09","filed_date":"2016-09-12","scope":"insider"},{"id":2911599,"accession":"0001140361-16-079565","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-079565","line_url":"/filing/0001140361-16-079565#line-1","is_derivative":false,"issuer_cik":"0001457130","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"AST","issuer_name_source":null,"issuer_url":"/issuer/0001457130","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9728.0,"shares_display":"9,728","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":34048.0,"total_display":"34,048.00","total_whole":"34,048","shares_owned_after":9608.0,"shares_owned_after_display":"9,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-08","filed_date":"2016-09-12","scope":"insider"},{"id":8100256,"accession":"0001140361-15-035226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-035226","line_url":"/filing/0001140361-15-035226#line-1","is_derivative":false,"issuer_cik":"0001457130","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"AST","issuer_name_source":null,"issuer_url":"/issuer/0001457130","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (VP and Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Operating Officer","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3760.0,"shares_display":"3,760","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":22560.0,"total_display":"22,560.00","total_whole":"22,560","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-15","filed_date":"2015-09-16","scope":"insider"},{"id":8962080,"accession":"0000886744-11-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886744-11-000083","line_url":"/filing/0000886744-11-000083#line-1","is_derivative":false,"issuer_cik":"0000886744","issuer_name":"GERON CORP","issuer_ticker":"GERN","issuer_name_source":null,"issuer_url":"/issuer/0000886744","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (SVP Alliance Mgmt & Operations)","role_mark":"O","role_mark_label":"Officer (SVP Alliance Mgmt & Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Alliance Mgmt & Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22591.0,"shares_display":"22,591","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":96689.48,"total_display":"96,689.48","total_whole":"96,689","shares_owned_after":328561.0,"shares_owned_after_display":"328,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-14","filed_date":"2011-06-16","scope":"insider"},{"id":9049494,"accession":"0000886744-11-000067","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000886744-11-000067","line_url":"/filing/0000886744-11-000067#line-4","is_derivative":false,"issuer_cik":"0000886744","issuer_name":"GERON CORP","issuer_ticker":"GERN","issuer_name_source":null,"issuer_url":"/issuer/0000886744","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (SVP Prgm Mgmt, Cell Therapies)","role_mark":"O","role_mark_label":"Officer (SVP Prgm Mgmt, Cell Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Prgm Mgmt, Cell Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":419.0,"shares_display":"419","price_per_share":4.47,"price_display":"4.47","price_state":"stated","total_value":1872.93,"total_display":"1,872.93","total_whole":"1,873","shares_owned_after":351152.0,"shares_owned_after_display":"351,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-24","filed_date":"2011-05-24","scope":"insider"},{"id":7314614,"accession":"0000886744-10-000063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886744-10-000063","line_url":"/filing/0000886744-10-000063#line-1","is_derivative":false,"issuer_cik":"0000886744","issuer_name":"GERON CORP","issuer_ticker":"GERN","issuer_name_source":null,"issuer_url":"/issuer/0000886744","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (VP Operations, Regen Med Progs)","role_mark":"O","role_mark_label":"Officer (VP Operations, Regen Med Progs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Operations, Regen Med Progs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8186.0,"shares_display":"8,186","price_per_share":5.43,"price_display":"5.43","price_state":"stated","total_value":44449.98,"total_display":"44,449.98","total_whole":"44,450","shares_owned_after":91571.0,"shares_owned_after_display":"91,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-02","filed_date":"2010-06-03","scope":"insider"},{"id":7419592,"accession":"0000886744-10-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886744-10-000051","line_url":"/filing/0000886744-10-000051#line-1","is_derivative":false,"issuer_cik":"0000886744","issuer_name":"GERON CORP","issuer_ticker":"GERN","issuer_name_source":null,"issuer_url":"/issuer/0000886744","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (VP Operations, Regen Med Progs)","role_mark":"O","role_mark_label":"Officer (VP Operations, Regen Med Progs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Operations, Regen Med Progs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":385.0,"shares_display":"385","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":1967.35,"total_display":"1,967.35","total_whole":"1,967","shares_owned_after":99757.0,"shares_owned_after_display":"99,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-24","filed_date":"2010-05-25","scope":"insider"},{"id":5723052,"accession":"0000886744-09-000081","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000886744-09-000081","line_url":"/filing/0000886744-09-000081#line-3","is_derivative":false,"issuer_cik":"0000886744","issuer_name":"GERON CORP","issuer_ticker":"GERN","issuer_name_source":null,"issuer_url":"/issuer/0000886744","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (VP Operations, Regen Med Progs)","role_mark":"O","role_mark_label":"Officer (VP Operations, Regen Med Progs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Operations, Regen Med Progs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":6.35,"price_display":"6.35","price_state":"stated","total_value":2540.0,"total_display":"2,540.00","total_whole":"2,540","shares_owned_after":10142.0,"shares_owned_after_display":"10,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-29","filed_date":"2009-06-01","scope":"insider"},{"id":5830243,"accession":"0000886744-09-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886744-09-000059","line_url":"/filing/0000886744-09-000059#line-1","is_derivative":false,"issuer_cik":"0000886744","issuer_name":"GERON CORP","issuer_ticker":"GERN","issuer_name_source":null,"issuer_url":"/issuer/0000886744","owner_cik":"0001457130","owner_name":"Spink Katharine E.","owner_display_name":"Spink Katharine E.","owner_url":"/insider/0001457130","role":"Officer (VP Operations, Regen Med Progs)","role_mark":"O","role_mark_label":"Officer (VP Operations, Regen Med Progs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Operations, Regen Med Progs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2864.0,"shares_display":"2,864","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":19332.0,"total_display":"19,332.00","total_whole":"19,332","shares_owned_after":10542.0,"shares_owned_after_display":"10,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-26","filed_date":"2009-05-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001572552","name":"Asterias Biotherapeutics, Inc.","url":"/issuer/0001572552","role":"Officer (Chief Operating Officer)","n_filings":7,"first_seen":"2015-09-16","last_seen":"2017-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0000886744","name":"GERON CORP","url":"/issuer/0000886744","role":"Officer (SVP Alliance Mgmt & Operations)","n_filings":6,"first_seen":"2009-05-28","last_seen":"2011-06-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001457130","retrieved_at":"2026-08-23T22:13:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}